On 11/7/23, Neogenomics Inc (NASDAQ: NEO) stock enjoyed a major increase of 14.2%, closing at $16.73. Relative to the market the stock has been weak over the last nine months but has risen 22.9% during […]
Novanta Inc (NASDAQ: NOVT) has reported E.P.S. of $0.59 for its third fiscal quarter (ending September 30) versus $0.63 for the same period a year ago — a decline of -6%. This performance was $-0.15 […]
For its first fiscal quarter (ending September 30), Coty Inc (NYSE: COTY) has reported a -100% decline in E.P.S. from $0.15 a year ago to $0.00 in the current quarter. This performance was $-0.17 short […]
United-Guardian Inc. (NASDAQ: UG) has reported E.P.S. of $0.14 for its third fiscal quarter (ending September 30) versus $0.07 for the same period a year ago — an increase of 100%. E.P.S. were $0.55 for […]
Trupanion Inc (NASDAQ: TRUP) stock suffered a major decline of -10.5% on 11/6/23. The shares closed at $23.40. The stock has risen 13.1% during the last week but has been extremely weak relative to the […]
American States Water Co (NYSE: AWR) has reported earnings for its third fiscal quarter (ending September 30) of $0.85 versus $0.69 for the same period a year ago — an increase of 23%. This performance […]
Recent exceptional negative changes in investment behavior have affected Rocky Mountain Chocolate Factory (NASDAQ: RMCF): negative upside/downside volume developed, and the stock fell on very heavy volume. Rocky Mountain Chocolate Factory (NASDAQ: RMCF). Significant negative […]
NAPCO Security Technologies Inc (NASDAQ: NSSC) has reported E.P.S. of $0.28 for its first fiscal quarter (ending September 30) versus $0.08 for the same period a year ago — an increase of 250%. Relative to […]
Celldex Therapeutics Inc (NASDAQ: CLDX) stock closed at $29.35 on 11/6/23 after a major increase of 13.0%. Relative to the market the stock has been weak over the last nine months but has risen 29.8% […]
OptimizeRX Corp (NASDAQ: OPRX) has reported E.P.S. of $-0.17 for its third fiscal quarter (ending September 30) versus $-0.19 for the same period a year ago. This performance was $-0.21 short of the consensus estimate […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research